Koyfin Home > Directory > Health Care > Pieris Pharma > Issuance of Common Stock

Pieris Pharma Issuance of Common Stock Chart (PIRS)

Pieris Pharma annual/quarterly Issuance of Common Stock from 2014 to 2020.
  • Pieris Pharma Issuance of Common Stock for the quarter ending September 09, 2020 was $10m a 97.70% increase of 9m year over year
  • Pieris Pharma Issuance of Common Stock for the last 12 months ending September 09, 2020 was $42m a 22.87% increase of 10m year over year
  • Pieris Pharma Annual Issuance of Common Stock for 2019 was $32m a -50.81% decrease of -16m from 2018
  • Pieris Pharma Annual Issuance of Common Stock for 2018 was $49m a 91.57% increase of 44m from 2017
  • Pieris Pharma Annual Issuance of Common Stock for 2017 was $4m a -272.15% decrease of -11m from 2016
Other Cash Flow Metrics:
  • Pieris Pharma Cash Flow from Operations for the quarter ending September 09, 2018 was $-14m a 67.31% decrease of -10m year over year
  • Pieris Pharma Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-21m a 96.92% decrease of -20m year over year
  • Pieris Pharma Total Revenue for the quarter ending September 09, 2018 was $8m a -117.52% decrease of -10m year over year
View Chart On Koyfin

Quarterly PIRS Issuance of Common Stock Data

09/2020$10m
06/2020$0m
12/2019$32m
09/2019$0m
06/2019$0m
12/2018$0m
09/2018$0m
06/2018$0m
03/2018$48m
12/2017$1m

Annual PIRS Issuance of Common Stock Data

2019$32m
2018$49m
2017$4m
2016$15m
2015$26m
2014$19m